This report provides comprehensive insights into the China Jaundice Meter market, presenting an analysis on industry trends, market share, key drivers, and revenue forecasts through 2035. As the healthcare sector in China prioritizes neonatal care, the demand for accurate jaundice detection devices is on the rise.
The economic impact of tariffs on "China Jaundice Meter".
China Jaundice Meter Market Growth Drivers
Rising Birth Rate and Focus on Neonatal Care: With over 10 million births annually, the Chinese government's focus on neonatal health is pushing demand for jaundice meters. Hospitals are adopting advanced jaundice meters to ensure early diagnosis and reduce the risk of kernicterus. Companies such as Dräger and Beijing M&B adopt proactive government tender participation and local partnerships to provide their products across urban and rural centers.
Technological Advancements: There are rapid advancements in non-invasive and portable jaundice meters, improving clinical workflow and patient comfort. For instance, Philips Healthcare has developed jaundice meters with Bluetooth connectivity and cloud-based data management, enabling real-time monitoring and reducing manual errors. These innovations support ongoing hospital digitalization efforts.
China Jaundice Meter Market Trends
Integration with Digital Health Records: Companies like M&B and Philips are integrating jaundice meters with hospital electronic medical records (EMR), streamlining workflow and enhancing patient data management. This trend is driving greater adoption in modern hospitals and new maternal and child health centers across major Chinese cities.
Growing Market for Home Care Solutions: With the growth in disposable incomes and increased health awareness, there is rising demand for jaundice meters that parents can use at home. Startups like Sino Medical Devices Technology launched affordable, easy-to-use handheld jaundice meters, targeting home healthcare and small clinics.
China Jaundice Meter Market Opportunities
Expansion in Rural Healthcare: Leading companies such as Dräger and M&B have substantial opportunities to penetrate rural regions through government healthcare schemes, addressing a market segment with historically low access to advanced neonatal diagnostics.
Strategic Partnerships and Distribution: Establishing partnerships with local medical device distributors and digital platforms can accelerate product reach. For example, Beijing M&B formed alliances with eHealth platforms to provide telemedicine-enabled jaundice screening kits.
China Jaundice Meter Market Revenue (USD Million), 2020-2035
The chart demonstrates robust revenue growth for the China Jaundice Meter market from USD 85 Million in 2020 to USD 238 Million by 2035, reflecting a CAGR of approximately 7.6%. Major revenue jumps are expected post-2025 as nationwide policy support, neonatal health awareness, and product innovation fuel hospital and home adoption. This upward trend underpins the growing significance of non-invasive jaundice detection across China’s public and private healthcare sectors.
China Jaundice Meter Market by Regions Share (%), 2025
The pie chart for 2025 illustrates that East China dominates the jaundice meter market with a 37% share, buoyed by advanced healthcare infrastructure and major hospitals. North China and South Central China follow with 22% and 18% shares, respectively, driven by increasing numbers of tier-2 and tier-3 city hospitals adopting neonatal screening devices. West and Northeast China represent emerging markets with 13% and 10% shares, reflecting recent healthcare investments and ongoing expansion by key market players.
China Jaundice Meter Recent Developments (Past 6 Months)
In March 2024, Beijing M&B Electronic Instruments Co., Ltd. announced a partnership with leading national hospitals to deploy their latest non-invasive jaundice meter model, the MBJ30, under a smart neonatal care program. The collaboration aims to implement cloud integration for seamless data access, improving diagnosis speed and hospital workflow efficiency.
Philips Healthcare received China NMPA approval for its next-generation jaundice meter in April 2024. This device features enhanced point-of-care usability and increased measurement accuracy, specifically designed for China’s rural clinics and township hospitals as part of health equalization programs.
In May 2024, Dräger China launched a portable, rechargeable jaundice meter targeted at home healthcare providers and urban community clinics, offering remote data sharing capabilities. The device has already seen pilot adoption in Shanghai and Guangzhou, highlighting growing demand for at-home neonatal monitoring in major Chinese cities.
Press Releases